news

Happy New Year 2025!

 

Conference in Moscow: Discussion of Quality-of-Life Improvement in Patients with Hepatic Cancer
Bovhyaluronidase azoximer significantly reduces exercise intolerance in patients with long-term pulmonary sequelae of COVID-19
Russia completes first time ever localization of an orphan drug, including biosynthesis of its drug substance
Experts: Adding Fabry disease to the list of high-cost nosologies is necessary to reduce patient mortality
Vaccination against influenza and pneumococcal infection can make a big contribution to the indicators of the national project Demography
New study: Imoferaza® improves prognosis of complex scar therapy
How to Protect Yourself from Pneumonia: Expert Advice
Breakthrough in Treatment of Nasopharyngeal and Esophageal Cancer: New Drug Available in Russia
Show more